MARKETSSun Pharma ILUMYA Gets USFDA Nod for Psoriatic ArthritisΒ Tabassum ChaudharyOctober 30, 2026October 30, 2026 October 30, 2026October 30, 2026 Sun Pharma touched a day high of Rs 1,802.40 on 30 October after the US FDA approved its drug ILUMYA for adults with psoriatic arthritis....
MARKETSBiocon Gets Health Canada Nod for Psoriasis AutoinjectorTabassum ChaudharyJuly 29, 2026July 29, 2026 July 29, 2026July 29, 2026 Biocon touched a day high of βΉ435.50 on Wednesday after its Canadian arm received Health Canada approval for the Yesintek autoinjector pen. Health Canada cleared...